vs
Astrana Health, Inc.（ASTH）とBGC Group, Inc.（BGC）の財務データ比較。上の社名をクリックして会社を切り替えられます
Astrana Health, Inc.の直近四半期売上が大きい（$950.5M vs $638.6M、BGC Group, Inc.の約1.5倍）。BGC Group, Inc.の純利益率が高く（2.3% vs 0.7%、差は1.6%）。Astrana Health, Inc.の前年同期比売上増加率が高い（42.9% vs 34.4%）。BGC Group, Inc.の直近四半期フリーキャッシュフローが多い（$175.1M vs $-6.0M）。過去8四半期でAstrana Health, Inc.の売上複合成長率が高い（53.3% vs 18.7%）
アストラナヘルス社は米国に本拠を置く価値基準型医療サービスプロバイダーで、主に米国全土の連邦医療保険対象高齢者層にサービスを提供している。訪問型プライマリケア、慢性疾患管理、ケアコーディネーションを通じ、患者の健康状態改善と不要な医療費削減を目指している。
BGCグループはニューヨークとロンドンに本社を置く米国のグローバル金融サービス企業です。元々は大手金融会社カンター・フィッツジェラルドの一部門として設立され、2004年に独立した事業体となりました。
ASTH vs BGC — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $950.5M | $638.6M |
| 純利益 | $6.6M | $14.4M |
| 粗利率 | — | — |
| 営業利益率 | 1.9% | 3.9% |
| 純利益率 | 0.7% | 2.3% |
| 売上前年比 | 42.9% | 34.4% |
| 純利益前年比 | 184.4% | -43.0% |
| EPS（希薄化後） | $0.12 | $0.03 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $950.5M | $638.6M | ||
| Q3 25 | $956.0M | $620.8M | ||
| Q2 25 | $654.8M | $648.0M | ||
| Q1 25 | $620.4M | $534.6M | ||
| Q4 24 | $665.2M | $475.2M | ||
| Q3 24 | $478.7M | $448.9M | ||
| Q2 24 | $486.3M | $435.0M | ||
| Q1 24 | $404.4M | $453.6M |
| Q4 25 | $6.6M | $14.4M | ||
| Q3 25 | $373.0K | $27.9M | ||
| Q2 25 | $9.4M | $57.5M | ||
| Q1 25 | $6.7M | $55.2M | ||
| Q4 24 | $-7.8M | $25.2M | ||
| Q3 24 | $16.1M | $14.7M | ||
| Q2 24 | $19.2M | $37.8M | ||
| Q1 24 | $14.8M | $49.2M |
| Q4 25 | 1.9% | 3.9% | ||
| Q3 25 | 2.0% | 5.4% | ||
| Q2 25 | 3.1% | 11.6% | ||
| Q1 25 | 3.3% | 15.0% | ||
| Q4 24 | 0.1% | 5.7% | ||
| Q3 24 | 5.9% | 4.4% | ||
| Q2 24 | 6.2% | 12.7% | ||
| Q1 24 | 7.5% | 15.7% |
| Q4 25 | 0.7% | 2.3% | ||
| Q3 25 | 0.0% | 4.5% | ||
| Q2 25 | 1.4% | 8.9% | ||
| Q1 25 | 1.1% | 10.3% | ||
| Q4 24 | -1.2% | 5.3% | ||
| Q3 24 | 3.4% | 3.3% | ||
| Q2 24 | 3.9% | 8.7% | ||
| Q1 24 | 3.7% | 10.8% |
| Q4 25 | $0.12 | $0.03 | ||
| Q3 25 | $0.01 | $0.06 | ||
| Q2 25 | $0.19 | $0.11 | ||
| Q1 25 | $0.14 | $0.11 | ||
| Q4 24 | $-0.14 | $0.04 | ||
| Q3 24 | $0.33 | $0.03 | ||
| Q2 24 | $0.40 | $0.08 | ||
| Q1 24 | $0.31 | $0.10 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $429.5M | $851.5M |
| 総負債低いほど良い | — | $1.5B |
| 株主資本純資産 | $779.3M | $972.5M |
| 総資産 | $2.2B | $4.4B |
| 負債/資本比率低いほどレバレッジが低い | — | 1.58× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $429.5M | $851.5M | ||
| Q3 25 | $463.4M | $774.9M | ||
| Q2 25 | $342.1M | $827.8M | ||
| Q1 25 | $260.9M | $966.4M | ||
| Q4 24 | $290.8M | $711.6M | ||
| Q3 24 | $350.3M | $563.5M | ||
| Q2 24 | $327.7M | $571.7M | ||
| Q1 24 | $337.3M | $566.8M |
| Q4 25 | — | $1.5B | ||
| Q3 25 | — | $1.8B | ||
| Q2 25 | — | $1.8B | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $1.4B | ||
| Q2 24 | — | $1.4B | ||
| Q1 24 | — | $945.0M |
| Q4 25 | $779.3M | $972.5M | ||
| Q3 25 | $775.5M | $965.3M | ||
| Q2 25 | $765.5M | $930.5M | ||
| Q1 25 | $745.4M | $963.8M | ||
| Q4 24 | $712.7M | $898.5M | ||
| Q3 24 | $704.6M | $860.1M | ||
| Q2 24 | $678.9M | $858.1M | ||
| Q1 24 | $653.5M | $912.1M |
| Q4 25 | $2.2B | $4.4B | ||
| Q3 25 | $2.2B | $5.8B | ||
| Q2 25 | $1.4B | $4.9B | ||
| Q1 25 | $1.3B | $4.9B | ||
| Q4 24 | $1.4B | $3.6B | ||
| Q3 24 | $1.3B | $4.4B | ||
| Q2 24 | $1.3B | $4.3B | ||
| Q1 24 | $1.2B | $4.4B |
| Q4 25 | — | 1.58× | ||
| Q3 25 | — | 1.90× | ||
| Q2 25 | — | 1.97× | ||
| Q1 25 | — | 1.19× | ||
| Q4 24 | — | 1.27× | ||
| Q3 24 | — | 1.68× | ||
| Q2 24 | — | 1.68× | ||
| Q1 24 | — | 1.04× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $-2.9M | $180.4M |
| フリーキャッシュフロー営業CF - 設備投資 | $-6.0M | $175.1M |
| FCFマージンFCF / 売上 | -0.6% | 27.4% |
| 設備投資強度設備投資 / 売上 | 0.3% | 0.8% |
| キャッシュ転換率営業CF / 純利益 | -0.44× | 12.55× |
| 直近12ヶ月FCF直近4四半期 | $104.5M | $372.9M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $-2.9M | $180.4M | ||
| Q3 25 | $10.0M | $141.9M | ||
| Q2 25 | $90.9M | $71.2M | ||
| Q1 25 | $16.6M | $839.0K | ||
| Q4 24 | $-10.9M | $251.9M | ||
| Q3 24 | $34.0M | $88.3M | ||
| Q2 24 | $23.2M | $-53.0M | ||
| Q1 24 | $6.0M | $28.1M |
| Q4 25 | $-6.0M | $175.1M | ||
| Q3 25 | $7.4M | $137.2M | ||
| Q2 25 | $89.5M | $65.0M | ||
| Q1 25 | $13.6M | $-4.4M | ||
| Q4 24 | $-13.5M | $245.6M | ||
| Q3 24 | $31.7M | $78.8M | ||
| Q2 24 | $20.4M | $-63.5M | ||
| Q1 24 | $5.6M | $24.9M |
| Q4 25 | -0.6% | 27.4% | ||
| Q3 25 | 0.8% | 22.1% | ||
| Q2 25 | 13.7% | 10.0% | ||
| Q1 25 | 2.2% | -0.8% | ||
| Q4 24 | -2.0% | 51.7% | ||
| Q3 24 | 6.6% | 17.5% | ||
| Q2 24 | 4.2% | -14.6% | ||
| Q1 24 | 1.4% | 5.5% |
| Q4 25 | 0.3% | 0.8% | ||
| Q3 25 | 0.3% | 0.8% | ||
| Q2 25 | 0.2% | 1.0% | ||
| Q1 25 | 0.5% | 1.0% | ||
| Q4 24 | 0.4% | 1.3% | ||
| Q3 24 | 0.5% | 2.1% | ||
| Q2 24 | 0.6% | 2.4% | ||
| Q1 24 | 0.1% | 0.7% |
| Q4 25 | -0.44× | 12.55× | ||
| Q3 25 | 26.69× | 5.09× | ||
| Q2 25 | 9.65× | 1.24× | ||
| Q1 25 | 2.48× | 0.02× | ||
| Q4 24 | — | 9.99× | ||
| Q3 24 | 2.11× | 5.99× | ||
| Q2 24 | 1.21× | -1.40× | ||
| Q1 24 | 0.40× | 0.57× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
BGC
| Commissions | $590.2M | 92% |
| Data Software And Post Trade | $36.7M | 6% |
| Fees From Related Parties | $4.6M | 1% |
